Publicaciones (27) Publicaciones de Cristina Burgui Alcaide

2023

  1. Assessment of Knowledge and Attitudes Over Time in Postacute COVID-19 Environments: Protocol for an Epidemiological Study

    JMIR Research Protocols, Vol. 12, Núm. 1

  2. Comparison of the Risk of Hospitalization and Severe Disease Among Co-circulating Severe Acute Respiratory Syndrome Coronavirus 2 Variants

    The Journal of infectious diseases, Vol. 227, Núm. 3, pp. 332-338

  3. Effect of COVID-19 vaccination on the SARS-CoV-2 transmission among social and household close contacts: A cohort study

    Journal of Infection and Public Health, Vol. 16, Núm. 3, pp. 410-417

  4. Effectiveness of hepatitis C antiviral treatment and feasibility of hepatitis C elimination goal

    Postgraduate Medicine, Vol. 135, Núm. 4, pp. 352-360

  5. Infecciones, hospitalizaciones y mortalidad por COVID-19 en Navarra entre febrero de 2020 y septiembre de 2022

    Anales del sistema sanitario de Navarra, Vol. 46, Núm. 2, pp. 61-70

  6. Infección, hospitalización y mortalidad por COVID-19 en Navarra, febrero de 2020 a septiembre de 2022

    Anales del sistema sanitario de Navarra, Vol. 46, Núm. 1

  7. Patient satisfaction with HIV care service in Spain: results from a cross-sectional patient survey

    AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV, Vol. 35, Núm. 6, pp. 892-898

  8. Risk reduction of hospitalisation and severe disease in vaccinated COVID-19 cases during the SARS-CoV-2 variant Omicron BA.1-predominant period, Navarre, Spain, January to March 2022

    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, Vol. 28, Núm. 5

  9. Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021

    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, Vol. 28, Núm. 47

  10. Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022

    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, Vol. 28, Núm. 47

2022

  1. Differences in Transmission between SARS-CoV-2 Alpha (B.1.1.7) and Delta (B.1.617.2) Variants

    Microbiology Spectrum, Vol. 10, Núm. 2

  2. Effectiveness of influenza vaccination in preventing influenza in primary care, Navarre, Spain, 2021/22

    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, Vol. 27, Núm. 26

  3. Epidemiologic Features and Control Measures during Monkeypox Outbreak, Spain, June 2022

    Emerging Infectious Diseases, Vol. 28, Núm. 9, pp. 1847-1851

  4. Seroprevalence of antibodies against SARS-CoV-2 and risk of COVID-19 in Navarre, Spain, May to July 2022

    Eurosurveillance, Vol. 27, Núm. 33

  5. Transmission of SARS-CoV-2 infection and risk factors in a cohort of close contacts

    Postgraduate Medicine, Vol. 134, Núm. 2, pp. 230-238